What does CUSIP 69366J200 represent in this 13F holders report?

CUSIP 69366J200 is the security identifier for PTCT - PTC THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held PTCT - PTC THERAPEUTICS, INC. - Common Stock in Q1 2015?

157 institutional investors reported PTCT - PTC THERAPEUTICS, INC. - Common Stock for Q1 2015. Use the holders table for investor-level position and value details.

PTC THERAPEUTICS, INC. - Common Stock (PTCT)

CUSIP: 69366J200

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class: Equity / Common Stock
Shares outstanding: 80,855,533
Total 13F shares: 31,473,162
Share change: +3,111,056
Total reported value: $1,915,082,191
Put/Call ratio: 158%
Price per share: $60.85
Number of holders: 157
Value change: +$210,644,324
Number of buys: 97
Number of sells: 71

Quarterly Holders Quick Answers

What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2015
Previous quarter: Q4 2014

Recent filing periods for CUSIP 69366J200:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	6.2%	5,040,381	$260,941,000	—	31 Dec 2014	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.9%	2,333,209	$120,791,000	—	31 Dec 2014	13F
Bain Capital Public Equity Management, LLC	13F	Company	2.6%	2,081,932	$107,782,000	—	31 Dec 2014	13F
BB BIOTECH AG	13F	Company	1.5%	1,227,912	$63,569,000	—	31 Dec 2014	13F
CREDIT SUISSE AG/	13F	Company	1.5%	1,183,177	$61,252,000	—	31 Dec 2014	13F
VANGUARD GROUP INC	13F	Company	1.5%	1,175,176	$60,839,000	—	31 Dec 2014	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.4%	1,135,130	$58,766,000	—	31 Dec 2014	13F
BlackRock Fund Advisors	13F	Company	1.3%	1,089,388	$56,398,000	—	31 Dec 2014	13F
Granahan Investment Management, LLC	13F	Company	1.1%	869,101	$44,993,000	—	31 Dec 2014	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.9%	731,310	$37,860,000	—	31 Dec 2014	13F
STATE STREET CORP	13F	Company	0.86%	695,897	$36,030,000	—	31 Dec 2014	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.83%	671,736	$34,776,000	—	31 Dec 2014	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.78%	627,372	$32,479,000	—	31 Dec 2014	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	0.75%	608,154	$31,484,000	—	31 Dec 2014	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.75%	603,308	$31,233,000	—	31 Dec 2014	13F
Camber Capital Management LP	13F	Company	0.65%	525,000	$27,179,000	—	31 Dec 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.51%	409,707	$21,211,000	—	31 Dec 2014	13F
FRANKLIN RESOURCES INC	13F	Company	0.49%	397,800	$20,594,000	—	31 Dec 2014	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.44%	352,615	$18,254,000	—	31 Dec 2014	13F
OppenheimerFunds, Inc.	13F	Company	0.39%	317,350	$16,429,000	—	31 Dec 2014	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.38%	304,600	$15,769,000	—	31 Dec 2014	13F
BLACKROCK ADVISORS LLC	13F	Company	0.37%	299,800	$15,520,000	—	31 Dec 2014	13F
NORTHERN TRUST CORP	13F	Company	0.35%	286,145	$14,814,000	—	31 Dec 2014	13F
LOOMIS SAYLES & CO L P	13F	Company	0.33%	263,918	$13,663,000	—	31 Dec 2014	13F
CITADEL ADVISORS LLC	13F	Company	0.32%	255,179	$13,210,000	—	31 Dec 2014	13F
EverPoint Asset Management, LLC	13F	Company	0.28%	229,400	$11,876,000	—	31 Dec 2014	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.27%	219,300	$11,353,000	—	31 Dec 2014	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.25%	200,186	$10,364,000	—	31 Dec 2014	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.23%	186,895	$9,676,000	—	31 Dec 2014	13F
CITY NATIONAL BANK	13F	Company	0.22%	175,779	$9,100,000	—	31 Dec 2014	13F
Point72 Asset Management, L.P.	13F	Company	0.21%	169,000	$8,749,000	—	31 Dec 2014	13F
Bank of New York Mellon Corp	13F	Company	0.18%	148,215	$7,673,000	—	31 Dec 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	146,088	$7,562,000	—	31 Dec 2014	13F
Cupps Capital Management, LLC	13F	Company	0.17%	135,074	$6,992,000	—	31 Dec 2014	13F
PFM Health Sciences, LP	13F	Company	0.16%	131,099	$6,787,000	—	31 Dec 2014	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.15%	125,000	$6,471,000	—	31 Dec 2014	13F
LORD, ABBETT & CO. LLC	13F	Company	0.15%	122,595	$6,347,000	—	31 Dec 2014	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0.15%	121,650	$6,298,000	—	31 Dec 2014	13F
Tekla Capital Management LLC	13F	Company	0.15%	119,150	$6,168,000	—	31 Dec 2014	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.14%	110,000	$5,695,000	—	31 Dec 2014	13F
Asset Management One Co., Ltd.	13F	Company	0.13%	102,865	$5,515,000	—	31 Dec 2014	13F
Invesco Ltd.	13F	Company	0.12%	100,123	$5,184,000	—	31 Dec 2014	13F
S.c.a. Candriam	13F	Individual	0.12%	100,000	$5,177,000	—	31 Dec 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.12%	95,802	$4,960,000	—	31 Dec 2014	13F
BlackRock Investment Management, LLC	13F	Company	0.11%	90,328	$4,676,000	—	31 Dec 2014	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.11%	90,117	$4,665,000	—	31 Dec 2014	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.11%	89,767	$4,647,000	—	31 Dec 2014	13F
Ghost Tree Capital, LLC	13F	Company	0.11%	85,000	$4,400,000	—	31 Dec 2014	13F
JPMORGAN CHASE & CO	13F	Company	0.09%	75,737	$3,921,000	—	31 Dec 2014	13F
Granite Point Capital Management, L.P.	13F	Company	0.09%	73,000	$3,779,000	—	31 Dec 2014	13F

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2015

As of 31 Mar 2015, PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,473,162 shares. The largest 10 holders included FMR LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, WELLINGTON MANAGEMENT GROUP LLP, BROOKSIDE CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, CREDIT SUISSE AG/, BB BIOTECH AG, BlackRock Fund Advisors, WELLS FARGO & COMPANY/MN, and PUTNAM INVESTMENTS LLC. This page lists 157 institutional shareholders reporting positions in this security for the Q1 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders

131

Q1 2015 holders

157

Holder diff

Investor	Q4 2014 Shares	Q1 2015 Shares	Share Diff	Share Chg %	Q4 2014 Value $	Q1 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.